Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin and Solifenacin for double J stent-related urinary symptoms
IRCT20200831048564N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamsulosin and solifenacin in Micturition disorder, ureterolithiasis and ureteral stent-related symptoms (USRS), sponsored by Mashhad University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
tamsulosinsolifenacin
03
Conditions
Micturition disorderureterolithiasisureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on IRCT20200831048564N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200831048564N1.